Becton, Dickinson and (BDX) Stock Research, Analysis & News

Quick Analysis on Becton, Dickinson and (BDX) Stock as of July 12, 2020

The Stock pays no dividend
Average trading volume is relatively low at 0
(See more information about Becton, Dickinson and (BDX) Stock below)

Becton, Dickinson and (BDX) Stock Profile Summary

Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The companys BD Medical segment produces medical devices, which are used in healthcare settings. This segments product line includes needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes, pen needles, and other drugs used in the treatment of diabetes; prefillable drug delivery devices; surgical blades/scalpels and regional anesthesia needles and trays; critical care monitoring devices; ophthalmic surgical instruments; and sharps disposal containers. Its BD Diagnostics segment provides products for the safe collection and transport of diagnostics specimens, as well as instrument systems and reagents to detect infectious diseases, healthcare-associated infections (HAI), and cancers. Its product line consists of integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing systems; molecular testing systems for sexually transmitted diseases and HAIs; microorganism identification and drug susceptibility systems; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; and plated media. Its BD Biosciences segment produces research and clinical tools that facilitate the study of cells and its components. Its product line comprises fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life sciences research; cell imaging systems; laboratory products for tissue culture and fluid handling; diagnostic assays; and cell culture media supplements for biopharmaceutical manufacturing. Becton serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Becton, Dickinson and (BDX) Stock Key Statistics Research and Analysis as of July 12, 2020

Becton, Dickinson and (BDX) Stock Competitor Research and Analysis

Abbott Laboratories (ABT)Baxter International Inc. (BAX)
Covidien plc (COV)Unitedhealth Group, Inc. (UNH)
WellPoint Inc. (WLP)Aetna Inc. (AET)

Mutual Funds with Becton, Dickinson and (BDX) Stock in its top 10 holdings

FundCategoryBDX Holding Percentage
Advance Capital I Core Equity RetailLarge Blend2.48%
Advance Capital I Equity Growth InstlMid-Cap Value1.73%
American Century Global Growth AWorld Stock1.76%

ETFs with Becton, Dickinson and (BDX) Stock in its top 10 holdings

Latest Market News on Becton, Dickinson and (BDX)

Click here to find the latest news on Becton, Dickinson and (BDX)

Looking for Market Opportunties?

Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

Abbott Laboratories (ABT)
Baxter International Inc. (BAX)
Covidien plc (COV)
Unitedhealth Group, Inc. (UNH)
WellPoint Inc. (WLP)
Aetna Inc. (AET)